Katsuki Okada
Overview
Explore the profile of Katsuki Okada including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
91
Citations
757
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nakai M, Iwanaga Y, Kanaoka K, Sumita Y, Nishioka Y, Myojin T, et al.
J Clin Pharmacol
. 2025 Mar;
PMID: 40029113
Clinical evidence of oral inotrope use for advanced heart failure (HF) is limited. This study investigated the contemporary use and association of oral inotropes with prognosis in the outpatient treatment...
2.
Matsuoka Y, Sotomi Y, Nakatani D, Okada K, Sunaga A, Kida H, et al.
J Am Heart Assoc
. 2025 Feb;
14(3):e037567.
PMID: 39895530
Background: Using machine learning for the phenotyping of patients with heart failure with preserved ejection fraction (HFpEF) has emerged as a novel approach to understanding the pathophysiology and stratifying the...
3.
Sugimoto K, Wada S, Konishi S, Sato J, Okada K, Kido S, et al.
J Imaging Inform Med
. 2025 Jan;
PMID: 39843717
Missed critical imaging findings, particularly those indicating cancer, are a common issue that can result in delays in patient follow-up and treatment. To address this, we developed a rule-based natural...
4.
Sakamoto D, Matsuoka Y, Nakatani D, Okada K, Sunaga A, Kida H, et al.
Open Heart
. 2025 Jan;
12(1).
PMID: 39832941
Background: Growth differentiation factor 15 (GDF15) is a cytokine responding to oxidative stress and inflammation, and it regulates appetite and energy balance. The association between GDF15 and clinical factors and...
5.
Sunaga A, Tanaka N, Egami Y, Minamiguchi H, Oka T, Kawasaki M, et al.
J Arrhythm
. 2025 Jan;
41(1):e13194.
PMID: 39817007
Background: Continuous anticoagulation based on the CHA2DS2-VASc score is recommended to prevent embolism caused by atrial fibrillation (AF), but it does not consider AF episodes. The Apple Watch's continuous heart...
6.
Matsunaga-Lee Y, Inoue K, Tanaka N, Masuda M, Watanabe T, Minamiguchi H, et al.
Heart Rhythm
. 2024 Dec;
PMID: 39701441
No abstract available.
7.
Sakamoto D, Sotomi Y, Matsuoka Y, Nakatani D, Okada K, Sunaga A, et al.
J Card Fail
. 2024 Nov;
PMID: 39557334
Objectives: N-terminal pro brain natriuretic peptide (NT-proBNP) is a biomarker for myocardial stress that is used in diagnosing and prognosticating heart failure (HF). However, its interpretation is complicated by clinical...
8.
Nakai M, Iwanaga Y, Kanaoka K, Sumita Y, Nishioka Y, Myojin T, et al.
Clin Pharmacol Ther
. 2024 Nov;
PMID: 39552436
Evidence of the effectiveness of β-blockers in heart failure (HF) and atrial fibrillation (AF) in a contemporary cohort is controversial. This study investigated the association between the use of β-blockers...
9.
Hoshida S, Watanabe T, Masunaga N, Shinoda Y, Seo M, Hayashi T, et al.
J Clin Med
. 2024 Oct;
13(19).
PMID: 39407970
: Coronary microvascular dysfunction (CMD) is associated with many heart diseases, including heart failure (HF) with preserved ejection fraction (HFpEF). Invasive examinations for CMD detection are difficult in older patients...
10.
Matsuoka Y, Sotomi Y, Hikoso S, Sunaga A, Nakatani D, Okada K, et al.
J Cardiol
. 2024 Sep;
PMID: 39251131
Background: In patients with persistent atrial fibrillation (AF), extensive ablation for substrate modification, such as linear ablation or complex fractionated atrial electrogram ablation in addition to pulmonary vein isolation (PVI)...